Bursitis

Musculoskeletal·MeSH: Bursitis

6 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
indocin	Assertio Holdings, Inc. (ASRT)
indocin	Zyla Life Sciences (ZCOR)
INDOCIN (suppositories and oral suspension)	Assertio Holdings, Inc. (ASRT)
INDOCIN Oral Suspension	Assertio Holdings, Inc. (ASRT)
indomethacin	Mylan II B.V. (MYL)
indomethacin	Amneal Pharmaceuticals, Inc. (AMRX)

BioSniper tracks 6 drugs in development for Bursitis across 4 companies.

There are 1 clinical trial targeting Bursitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.